• PGI31 Impact of Treatment Response on Health Utilities and Work Productivity Among Patients With Irritable Bowel Syndrome With Constipation- Pooled Results From Phase III Clinical Trials

    Nov 1, 2012, 00:00

  • PRM80 Proportional Hazards Assumption and Its Impact on Results of Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PUK23 Burden of Chronic Kidney Disease in German Diabetes Patients, a Systematic Literature Review and Data Gap Analysis

    Nov 1, 2012, 00:00

  • CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?

    Nov 1, 2012, 00:00

  • PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

    Nov 1, 2012, 00:00

  • PMD39 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

    Nov 1, 2012, 00:00

  • PHP2 Economic Cost Savings of Technological Improvement for Lower-Level Hospitals- A Pilot Study in China

    Nov 1, 2012, 00:00

  • PMD63 A Review of Economic Evaluation Models for Cardiac Resynchronization Therapy With Implantable Cardioverter Defibrillators in Patients With Heart Failure

    Nov 1, 2012, 00:00

  • PCV3 One-Year Outcomes and Prognostic Factors in Severe Sepsis and Septic Shock Survivors

    Nov 1, 2012, 00:00

  • PRM115 Modelling the Relationship Between Disease Severity and Utility in Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan- The Road Ahead?

    Nov 1, 2012, 00:00

  • PCN111 The Value of Personalizing Medicine- Medical Oncologists' and Patients' Perspectives on Genomic Testing of Breast Tumours in Chemotherapy Treatment Decisions

    Nov 1, 2012, 00:00

  • PHS11 Relationship Between Physical Function and Muscle Strength in the United States Elderly Population

    Nov 1, 2012, 00:00

  • PCV48 Systematic Review of Cost-Effectiveness Models for Pharmacologic Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PHS46 Cost-Effectiveness of a Secondary Prevention Program in Patients With Myocardial Infarction- Results from a Randomised Controlled Trial (Proactive Heart)

    Nov 1, 2012, 00:00

  • PHS40 An Example of Irrational Decision Making in the Elderly- Why are Pharmacological Therapies Preferentially Reimbursed Over Non-Pharmacological Therapies for Insomnia?

    Nov 1, 2012, 00:00

  • PHS65 Mapping the Disease-Specific FACT-P to the Preference-Based EQ-5D in Castration-Resistant Prostate Cancer

    Nov 1, 2012, 00:00

  • PRM2 Assessing Relative Clinical Value Within Three Metastatic Diseases

    Nov 1, 2012, 00:00

  • QL4 The Impact of Disease Information on General Public Preferences for Health States- Comparing Labeling, Disease-Specific, and Adaptation Information

    Nov 1, 2012, 00:00

  • PCN46 Cost-Efficacy Analysis of Licensed Drugs for the Treatment of Metastatic Castrate Resistant Prostate Cancer Post Docetaxel Based on Hospital Drug Evaluation Methodology in Spain

    Nov 1, 2012, 00:00

  • PHP127 Reimbursement of Orphan Drugs- What is the Difference?

    Nov 1, 2012, 00:00

  • PIN18 Rates of Influenza Complications by High Risk Group

    Nov 1, 2012, 00:00

  • PMD9 A Comparative Assessment of Cost Implications of Novel Drug Versus Novel Device-Based Treatments for Stroke Prevention in Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PMD75 Does Presenting Follow-Up Test Information Affect People's Preferences for Colorectal Cancer Screening Tests? A Discrete Choice Experiment

    Nov 1, 2012, 00:00

  • PHP79 Review of Research Guidelines for Economic Evaluation Proposed by the Government and Government-Funded Research Groups in Japan

    Nov 1, 2012, 00:00

  • PRM119 Mapping Between Composite Measures in Psoriatic Arthritis and the SF-6D- Analysis From the Grace Dataset

    Nov 1, 2012, 00:00

  • PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia

    Nov 1, 2012, 00:00

  • PCV102 Characteristics Influencing Japanese Atrial Fibrillation Patients Preferences for Anticoagulants Use

    Nov 1, 2012, 00:00

  • PDB31 The Prevalence and Burden of Comorbid Hypertension and Obesity Among Patients With Type 2 Diabetes in Urban China

    Nov 1, 2012, 00:00

  • PIH37 Trends of Quality of Life in South Korean Adults During 2007-2010

    Nov 1, 2012, 00:00

  • PUK15 Sevelamer in Early Stages Nondialysis-Dependent Chronic Kidney Disease (NDD-CKD) Dominates Calcium Carbonate Through Reduction of Deaths and Hospitalizations

    Nov 1, 2012, 00:00

  • PDB22 The Direct Medical Cost for Diabetes Mellitus (DM) Related Complications in China

    Nov 1, 2012, 00:00

  • PCV16 Use of ACE Inhibitors in Serbia in 2009 and 2010

    Nov 1, 2012, 00:00

  • PND4 Capsaicin 8% Patch Monotherapy for Treatment of Post-Herpetic Neuralgia- Integrated Analysis of Phase III Studies

    Nov 1, 2012, 00:00

  • PRM91 How Do Patients With Different Conditions Describe Their Pain?

    Nov 1, 2012, 00:00

  • PND16 Qualitative Research Describing Patients' Perspectives of Successful Prophylactic Treatment With Botulinum Toxin Type a for Chronic Migraine

    Nov 1, 2012, 00:00

  • PDB26 Evidence Requirements in Australia for Drug Reimbursement- The Survival of Cost Minimisation Analysis

    Nov 1, 2012, 00:00

  • PHS75 Analysis of Costs and Reimbursement of Hospital Treatment of Venous Thromboembolism in Poland

    Nov 1, 2012, 00:00

  • MO2 Impact of Structural Assumptions on Cost-Effectiveness Outcomes- Towards a Standardized Cost-Effectiveness Model for Adjuvant Breast Cancer Therapies

    Nov 1, 2012, 00:00

  • PMS20 Total Health Care Costs Associated With Rheumatoid Arthritis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PMH19 A Rehabilitation Intervention to Help People With Severe Mental Illness Obtain and Keep a Paid Job- The Economic Evaluation

    Nov 1, 2012, 00:00

  • PHS38 Cost-Effectiveness Analysis of a Helpline for Suicide Prevention

    Nov 1, 2012, 00:00

  • PHP187 Pharmacovigilance and the Case Study of VIOXX

    Nov 1, 2012, 00:00

  • PCN157 Conceptual Framework for the Evaluation of Patient Access Schemes (PAS) in the EU

    Nov 1, 2012, 00:00

  • PHP68 The Effect of Resetting the Clock in Health Care

    Nov 1, 2012, 00:00

  • RU3 Some Issues With the Icer in Technology Assessments of Screening Interventions for Rare Conditions

    Nov 1, 2012, 00:00

  • PMD61 Cost-Effectiveness of Positron Emission Tomography in Head and Neck Squamous Cell Carcinoma- A Systematic Review

    Nov 1, 2012, 00:00

  • PDB18 Direct Medical Costs of Diabetes Mellitus in China- Annual Cost of Illness and Long-Term Projections Using a Validated Diabetes Model

    Nov 1, 2012, 00:00

  • PHP31 The Value of Investigational Medical Products

    Nov 1, 2012, 00:00

  • PHP48 Health Financing for Prisoners with HIV- Lesson Learned from Indonesia

    Nov 1, 2012, 00:00

  • PSY38 Spontaneous and Probed Disease-Defining Concepts Identified Through Concept Elicitation Interviews in Chronic Low Back Pain

    Nov 1, 2012, 00:00

  • PIH10 Utility Values for Use in Health Care Decision Making for Older Frail Adults

    Nov 1, 2012, 00:00

  • PIH2 Duloxetine Use in Pregnancy- A Prospective, Comparative Study of Exposed Infants

    Nov 1, 2012, 00:00

  • PHP90 Japanese Pricing Reform in April 2012- Toward Cost Containment

    Nov 1, 2012, 00:00

  • PDB60 Preliminary Results on the Reliability and Validity of the Worry Subscale of the Hypoglycaemic Fear Survey-II for Assessing the Impact of Fear for Hypoglycemia on the Health-Related Quality of Life of Type 2 Diabetes Mellitus Patients ...

    Nov 1, 2012, 00:00

  • PHP60 Assessment of Geographic Pharmacy Accessibility in Qom (Iran)- a Geographic Information System Analysis

    Nov 1, 2012, 00:00

  • PUK2 Issues in the Systematic Review of Drugs for Rare Diseases- A Case Study of Eculizumab for aHUS

    Nov 1, 2012, 00:00

  • PCV23 Economic Evaluation of Ezetimibe Co-Administration for High Coronary Heart Disease (CHD) Risk Patients Not at Goal With Current Statin Therapy in Thailand

    Nov 1, 2012, 00:00

  • MA1 Utilization of Disease Modifying Agents in Multiple Sclerosis- Analysis From an Italian Administrative Database

    Nov 1, 2012, 00:00

  • PCN16 Comparison of the Efficacy and Cost of Novel Targeted Cancer Therapies

    Nov 1, 2012, 00:00

  • PHS13 Costs Analysis of a Mobile Phone Telemonitoring System for Glycaemic Control in Patients With Diabetes Mellitus (DM) in Spain- Preliminary Results

    Nov 1, 2012, 00:00

  • PSY6 Economic Efficiency of Ferric Carboxymaltose to Treat or Prevent Iron Deficiency Anemia- Value to the Portuguese Hospitals

    Nov 1, 2012, 00:00

  • PMS59 Impact of Comorbidities on Measuring Indirect Utility by the Medical Outcomes Study Short Form 6D in Lower-Limb Osteoarthritis

    Nov 1, 2012, 00:00

  • PND10 Economic Evaluation of Interferon âeta-1A Versus Interferon âeta-1B in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran

    Nov 1, 2012, 00:00

  • PHP81 Factors Influencing Interprofessional Collaboration- A Literature Review from 2004-2011

    Nov 1, 2012, 00:00

  • PCV4 The Optimal Interval of Framingham Risk Score to Detect Cardiovasular Disease in Healthy Adults- A Large Cohort Study in Japan

    Nov 1, 2012, 00:00

  • PND56 Assessing the Quality of Life in a Spanish Population With Multiple Sclerosis- The Slims Study

    Nov 1, 2012, 00:00

  • PIN16 Tuberculosis Treatment Outcomes in Patients With and Without Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PCV100 Comparison of Health-Related Work Impairment in Russian Patients with US and 5EU

    Nov 1, 2012, 00:00

  • PGI28 Gastroesophageal Reflux Disease- Impact on Work Productivity and Daily Life Activities of Daytime Workers. A French Cross Sectional Study (ACTA)

    Nov 1, 2012, 00:00

  • PIN2 Estimating the Additive Effects of Length of Stay on Contracting Clostridium Difficile Infection

    Nov 1, 2012, 00:00

  • PMS15 An Economic Evaluation of Denosumab in the Treatment of Postmenopausal Osteoporosis in a Taiwanese Setting

    Nov 1, 2012, 00:00

  • PDB7 Network Meta-Analysis of Fixed Dose Combination Therapies for the First-Line Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PMD16 The Budgetary Impact of Using the Simtomax® Testing Kit for the Diagnosis of Coeliac Disease in the UK

    Nov 1, 2012, 00:00

  • PIN47 Cost-Effectiveness Analysis of the Primovaccination of Newborns Against Tuberculosis in Slovakia

    Nov 1, 2012, 00:00

  • PCV55 A Cost-Effectiveness Analysis of Coralan® (Ivabradine) Plus Standard Care Versus Standard Care Alone in Chronic Heart Failure

    Nov 1, 2012, 00:00

  • PHS89 How Can We Measure the Impact of Clinical Pharmacy Interventions? A Retrospective Drug Cost Analysis

    Nov 1, 2012, 00:00

  • PCN115 Quality of Life in Lung Cancer Patients During Adjuvant or Palliative Chemotherapy

    Nov 1, 2012, 00:00

  • ISPOR 5TH Asia-Pacific Conference Research Abstracts Author Index

    Nov 1, 2012, 00:00

  • PRS1 The Use of Montelukast and Neuropsychiatric Disturbances Among Pediatric Asthmatics- A Nested Case-Control Study

    Nov 1, 2012, 00:00

  • PCV31 Cost-Effectiveness of Apixaban Versus Enoxaparin for the Prevention of Postsurgical Venous Thromboembolism in Korea

    Nov 1, 2012, 00:00

  • PMS15 Determinants of Total Health Care Costs Associated With Ankylosing Spondylitis Prevalent Cases in Turkey

    Nov 1, 2012, 00:00

  • PIN29 Length of Stay and Cost Due to Recurrent Clostridium Difficile Infections (CDI) at a University Hospital in Finland

    Nov 1, 2012, 00:00

  • PHP101 The Implementation of Diagnostic Related Groups (DRGs) in Gree One Move Forward to Efficiency

    Nov 1, 2012, 00:00

  • PCV37 VIP Study- Incremental Cost During Hospitalization After Total Knee and Hip Arthroplasty in Brazilian Health Care Services

    Nov 1, 2012, 00:00

  • PCV64 Cost-Effectiveness of Ticagrelor in the Management of Acute Coronary Syndromes in Belgium

    Nov 1, 2012, 00:00

  • PIH44 Contraceptive Utilization in Women Who Had an Abortion- A Canadian Cohort-Study

    Nov 1, 2012, 00:00

  • PHS12 Meta-Analysis of Parkinson's Disease Risk With Hypertension, Serum Total Cholesterol, and Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PRM48 The Half-Cycle “Correction”- How Much of a Correction is it?

    Nov 1, 2012, 00:00

  • PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA)

    Nov 1, 2012, 00:00

  • PHP88 A Reimbursement Method for the Public Health Centers in Greece

    Nov 1, 2012, 00:00

  • PDB11 Efficacy of Exentaide in Type 2 Diabetes Mellitus in a Local Hospital in Taiwan- a Pilot Study

    Nov 1, 2012, 00:00

  • PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder

    Nov 1, 2012, 00:00

  • PHP1 Incorporating the Patient's Voice Into the Assessment of Medical Devices- A Comparison of the United States and Europe

    Nov 1, 2012, 00:00

  • PND34 Long-Term Effects on Costs and Quality Adjusted Life Years of Patients With Relapsing-Remitting Multiple Sclerosis Treated With Laquinimod- Results Based on the Allegro and Bravo Trials

    Nov 1, 2012, 00:00

  • PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia

    Nov 1, 2012, 00:00

  • PRS13 Variation of Cost of Chronic Obstructive Lung Disease in Adults in Germany- A Systematic Review

    Nov 1, 2012, 00:00

  • PRM130 Translatability of Response Sets Used in Patient Reported Outcomes and Best Practices for Development

    Nov 1, 2012, 00:00

  • PHP54 Chemical Drug Price Index Study

    Nov 1, 2012, 00:00

  • PCN19 Cost-Effectiveness Analysis of Temsirolimus in Patients With Poor Risk Renal-Cell Carcinoma

    Nov 1, 2012, 00:00

  • PRM4 QALY and Productivity Loss- Empirical Evidence for “Double Counting”

    Nov 1, 2012, 00:00

  • PMD34 Economic Comparative Evaluation of a Surgical Film Dressing in the Management of Post-Operative Surgical Wounds. An Inexepensive and Simple Solution to a Costly Problem

    Nov 1, 2012, 00:00

  • PMS1 Irrational Use of Steroids- A Warning for the Health Care System

    Nov 1, 2012, 00:00

  • PHP65 Quality of Care- Reference and Counter Reference from Family Physicians and Rheumatologists' Perspectives– A Pilot Study

    Nov 1, 2012, 00:00

  • PMS61 Health-Related Quality of Life After Vertebral Fracture- Differences Between the EQ-5D and Time-Trade-Off Instruments

    Nov 1, 2012, 00:00

  • PRM38 Measurement Properties of the Spanish Version of the Pediatric Promis Fatigue Item Bank

    Nov 1, 2012, 00:00

  • PHP110 Real-World Diagnosis and Treatment Patterns of Iron Deficiency Anemia in China

    Nov 1, 2012, 00:00

  • PCN127 Policy Maker, Please Carefully Consider Your Needs- Does Outcomes Research of Bortezomib for Advanced Multiple Myeloma Reduce Uncertainty?

    Nov 1, 2012, 00:00

  • PRM141 Combining an Ordered Logit Model With Individual Patient-Level Data to Robustly Estimate Within-Category Visual Acuity Starting Distributions- An Innovative Modeling Approach in the Case of Vitreomacular Traction

    Nov 1, 2012, 00:00

  • MO4 Treatment Discontinuation in Economic Modelling of Oncology Therapies- Systematic Review and Best Practices Analysis

    Nov 1, 2012, 00:00

  • PMD66 Health-Economic Analysis of the Systematic Use of Single-Hand Secured Huber Needles (Positive-Pressure) in French Hospitals

    Nov 1, 2012, 00:00

  • PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)

    Nov 1, 2012, 00:00

  • PHP125 An Early Assessment of the German Federal Joint Commission Resolutions of Additional Clinical Benefit

    Nov 1, 2012, 00:00

  • PMD45 Estimating Economic Impact of Angiogenesis-Specific Imaging in Metastatic Breast Cancer

    Nov 1, 2012, 00:00

  • PIN4 The Impact of Pharmacist-Led Antimicrobial Stewardship in Intensive Care Units in a Regional Hospital in Taiwan

    Nov 1, 2012, 00:00

  • PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach

    Nov 1, 2012, 00:00

  • CA3 Use of Health Care Administrative Databases to Estimate the Burden of Breast Cancer

    Nov 1, 2012, 00:00

  • PRM2 Development and Validation of a Health Economic Model for Corticosteroid-Induced Osteoporosis in Postmenopausal Women With Rheumatoid Arthritis in Japan

    Nov 1, 2012, 00:00

  • PMD37 Forecasting the Prevalence and Economic Burden of Atrial Fibrillation in Selected Countries, 2010-2025

    Nov 1, 2012, 00:00

  • PRS46 Health Care Resource Use of Patients With Cystic Fibrosis (CF) in the UK

    Nov 1, 2012, 00:00

  • PCV58 The Cost Effectiveness of Amlodipine Valsartan and Hydrochlorothiazide Single Pill Combination in Turkey

    Nov 1, 2012, 00:00

  • PIN57 Economic Evaluation of 13-Valent Pneumococcal Vaccine in High Risk Pediatric Population, From the Public Payer Perspective in Brazil

    Nov 1, 2012, 00:00

  • PSY37 Patient-Reported Outcome (PRO) Assessments in Systemic Lupus Erythematosus (SLE)

    Nov 1, 2012, 00:00

  • PGI2 Infliximab Reduces the Risk of Surgical Interventions and Hospitalization in Patients With Inflammatory Bowel Disease

    Nov 1, 2012, 00:00

  • PDB21 Direct Medical Costs of Diabetes-Related Complications in India

    Nov 1, 2012, 00:00

  • PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • DB4 Patient-Reported Hypoglycaemia in Real-World Settings in Seven European Countries

    Nov 1, 2012, 00:00

  • PRS47 Analysis of New Prescriptions for Long-Acting β2-Agonists in Five European Countries in 2011

    Nov 1, 2012, 00:00

  • PMD43 Comparison of Actual Costs Versus DRG Revenue of Cervical Arthroplasty in Patients With Degenerative Disc Disease in Germany

    Nov 1, 2012, 00:00

  • PSY19 Access to Care and Health Outcomes Among the Hemophilia A Population in Developing Countries- A Comparison Between Philippines and Colombia

    Nov 1, 2012, 00:00

  • PIN16 Cost-Effectiveness of Rotavirus Immunization in Indonesia Taking Breastfeeding Patterns Into Account

    Nov 1, 2012, 00:00

  • PHS14 Clinical and Economic Analysis of “MoliCare® Premium Extra Soft” Diapers Efficient Application for Dermatitis and Pressure Ulcers' Prophylaxis for Immobile Urinary-Incontinent Patients

    Nov 1, 2012, 00:00

  • PMD26 Cost Effectiveness of HIV Testing in Non-Traditional Settings – the Hints Study

    Nov 1, 2012, 00:00

  • PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies

    Nov 1, 2012, 00:00

  • PMS69 Key Drivers for Pricing and Reimbursement for Biologic Drugs in France

    Nov 1, 2012, 00:00

  • PIN37 The Economic Burden of Initial Empiric Antibiotic Failure on Health Care Resource Utilization for Hospitalized Patients With Complicated Intra-Abdominal Infections (cIAIs) in Greece

    Nov 1, 2012, 00:00

  • PSY15 Impact of Chronic Immune-Mediated Inflammatory Diseases on Work Productivity- Literature Review

    Nov 1, 2012, 00:00

  • PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • PHS58 Change in Health-Related Quality of Life After Occpational Therapy in Community-Dwelling Dependent Elderly- A Randomised Controled Trial

    Nov 1, 2012, 00:00

  • PHP161 Integration of Value of Information Into the Decision Making Process in Ireland

    Nov 1, 2012, 00:00

  • PRM52 Minimum Run-Time Requirements to Reduce Monte Carlo Error in Stochastic Simulations

    Nov 1, 2012, 00:00

  • PRM82 Verification of Proportional Hazards Assumption in Cost-Effectiveness Analysis (CEA)

    Nov 1, 2012, 00:00

  • PCN3 Improvement of the 3rd Generation Colorectal Cancer Gene Chip

    Nov 1, 2012, 00:00

  • PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing?

    Nov 1, 2012, 00:00

  • PRM40 Efficacy of Liraglutide Compared to Exenatide and Insulin Glargine in Patients With Diabetes Type 2- A Meta-Analysis

    Nov 1, 2012, 00:00

  • PIH35 Disability-Adjusted-Life-Years (DALYs) Loss in Postmenopausal Women with Osteoporosis

    Nov 1, 2012, 00:00

  • PCN86 Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System

    Nov 1, 2012, 00:00

  • PSY48 Developing a National Outcomes Treatment Registry for Hepatitis C Patients in the Era of the DAAs

    Nov 1, 2012, 00:00

  • PHP82 Health Care Utilization Research in Germany- Characterization of the Nordbaden Database

    Nov 1, 2012, 00:00

  • PCN63 The Relative Value of Dasatinib Versus Imatinib as First-Line Treatment for Chronic Myeloid Leukemia

    Nov 1, 2012, 00:00

  • PND66 Therapeutic Equivalence as a Means of Improving the Efficiency in the Treatment of Multiple Sclerosis

    Nov 1, 2012, 00:00

  • PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany

    Nov 1, 2012, 00:00

  • PSU19 Does the Novel Renal Marker NGAL (Neutrophil Gelatinase-Associated Lipocalin) Result in Cost Savings in Patients With Renal Impairment Following Cardiac Surgery?

    Nov 1, 2012, 00:00

  • PCN156 Value Based Pricing in the UK; Industry Stakeholders' Perspectives

    Nov 1, 2012, 00:00

  • PDB10 Effectiveness of Vildagliptin Compared to Sulfonylureas in Type 2 Diabetes Patients in Germany- Results From a Large Real-Life Cohort Study

    Nov 1, 2012, 00:00

  • PHP27 The Effect of Retirement on Mental Health

    Nov 1, 2012, 00:00

  • PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease

    Nov 1, 2012, 00:00

  • PIN17 Cost-Utility Analysis of Pneumococcal Nontypeable Haemophilus Influenza Protein-D Conjugate Vaccine (PHiD-CV) in Hong Kong Using Transmission Dynamic Model

    Nov 1, 2012, 00:00

  • PHS62 Assessment of Patient Satisfaction With Chronic Treatment Using the European Patient Survey in Atrial Fibrillation (EUPS-AF)

    Nov 1, 2012, 00:00

  • PHS29 Cost of Treating Patients With Obstructive Sleep Apnea/Hypopnea Sydrome in the Sotiria Chest Hospital in Greece

    Nov 1, 2012, 00:00

  • PCN1 Use of the 5-HT3-RA Antiemetics in the Prevention and Treatment of Radiation Induced Nausea and Vomiting

    Nov 1, 2012, 00:00

  • PHS69 Impact Assessment of Minnesota Model for Alcohol Rehabilitation in Hospitalized Patients

    Nov 1, 2012, 00:00

  • PDB2 Epidemiology, Patient Burden and Related Costs of Obesity in India

    Nov 1, 2012, 00:00

  • QL1 EQ-5D-5L Valuation Project for the Spanish Population – A Descriptive Overview and Preliminary Results

    Nov 1, 2012, 00:00

  • PRM87 Cross-Cultural Validation of the Huntington Quality of Life Instrument in Spain

    Nov 1, 2012, 00:00

  • PHS64 Shared Decision Making in Secondary Care- Rheumatologic Patient's Perspective

    Nov 1, 2012, 00:00

  • PCN54 Economic Burden Associated With Pancreatic Cancer in Europe

    Nov 1, 2012, 00:00

  • PND22 Descriptive Analysis of the Direct Costs of Relapsing-Remitting Multiple Sclerosis in the Mexican Setting

    Nov 1, 2012, 00:00

  • UT3 Estimating Preference-Based Index from Cancer-Specific Quality of Life Measures for Use in Cost-Utility-Analysis

    Nov 1, 2012, 00:00

  • PGI38 The Consumption of Proton-Pump Inhibitors in Slovakia

    Nov 1, 2012, 00:00

  • PSS13 Cost-Effectiveness of Specialized Treatment Based on Cognitive Behavioural Therapy Versus Usual Care for Tinnitus

    Nov 1, 2012, 00:00

  • PGI35 Health-Related Quality of Life in Patients With Haemophilia and Inhibitors on Prophylaxis With Anti-Inhibitor Complex Concentrate- Results From the Pro-Feiba Study

    Nov 1, 2012, 00:00

  • DB1 Epidemiology, Treatment and Economic Burden of Type 2 Diabetes Mellitus With Nephropathy Complications in China

    Nov 1, 2012, 00:00

  • PND24 Methodological Considerations in Cost of Illness Studies on Alzheimer Disease

    Nov 1, 2012, 00:00

  • PHS54 Use of Health Care Administrative Databases to Estimate the Health Care Burden of Bone or Bone Marrow Metastatic Deases in Breast Cancer Patients- A Population-Based Study

    Nov 1, 2012, 00:00

  • PRM102 Validation of the Russian Version of Schizophrenia Quality of Life Questionnaire (S-QoL)

    Nov 1, 2012, 00:00

  • PRM49 EQ-5D Versus Disease-Specific HR-QoL Instruments – No Contest?

    Nov 1, 2012, 00:00

  • PHP20 Real-World Utilization Pattern of Biologics in Rheumatoid Arthritis- A Population-Based Study

    Nov 1, 2012, 00:00

  • PRM1 What is the Evidence on Using Selected Types of Sutures for Abdominal Surgery – Novel Approach to Create Dynamic Tool for Colleting and Reviewing Available Data

    Nov 1, 2012, 00:00

  • PHS79 The Analysis of the Formulary Committees in Kazakhstani Regions

    Nov 1, 2012, 00:00

  • PSU7 Seasonal Periodicity of Secondary Hip Replacement After Femoral Neck Fractures With Reduction Internal Screw Fixation Aged Over 60

    Nov 1, 2012, 00:00

  • PRM129 Final Reports for Translation and Linguistic Validation of Clinical Outcome Assessments

    Nov 1, 2012, 00:00

  • PMD35 Cost Analysis of an Implantable Loop Recorder, Reveal© XT, for the Diagnosis of Atrial Fibrillation in Patients Who Underwent Cryptogenic Stroke From the Perspective of a Tertiary Spanish Hospital

    Nov 1, 2012, 00:00

  • PHS94 Involvement of CNS Specialists in Health Care Provision for Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)- New Data from Nordbaden, Germany, 2003 - 2009

    Nov 1, 2012, 00:00

  • PDB14 Prevalence of Hypertension and/or Obesity in Patients With Type 2 Diabetes Mellitus in Asia- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in Germany

    Nov 1, 2012, 00:00

  • PSY17 Estimating the Direct Costs of Patients Treated With Eltrombopag in the French Setting

    Nov 1, 2012, 00:00

  • PSS29 Assessing the Clinical Meaningfulness of 1-Line Average Change in Visual Acuity Among Patients With Diabetic Macular Edema- Evidence From Health-Related Quality of Life Changes

    Nov 1, 2012, 00:00

  • PSU30 Effects of Different Clinical Practices of Laparoscopic Surgery for Endometriosis Treatment on Cost of Therapy

    Nov 1, 2012, 00:00

  • PIN42 Cost-Effectiveness-Analysis of the Combination- Therapy Telaprevir, Peg-IFNα2a and Ribavirin in Patients With Chronic Hepatitis-C in Austria

    Nov 1, 2012, 00:00

  • PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case

    Nov 1, 2012, 00:00

  • PMS4 Inhibition of Carrageenan-Induced Edema by Stachys Fruticulosa Extract in Rats

    Nov 1, 2012, 00:00

  • PHP103 Challenges and Future Prospects of Nursing Workforce in Greece

    Nov 1, 2012, 00:00

  • PCN21 Melody Brasil- Real World Health Outcomes of the Treatment of Metastatic Melanoma Patients in the Brazilian Health System

    Nov 1, 2012, 00:00

  • PHS42 Cost-Effectiveness of Infant Vaccination With 10 and 13-Valent Pneumococcal Conjugate Vaccines in the Russian Federation

    Nov 1, 2012, 00:00

  • PSS5 New Formulation of Travoprost Reduces Dry Eye Occurrence and Costs in Glaucoma Patients- Model-Based Results for Hong Kong

    Nov 1, 2012, 00:00

  • PIH24 Economic Evaluation of Ulipristal Acetate Tablets for the Treatment of Patients with Moderate and Severe Symptoms of Uterine Fibroids

    Nov 1, 2012, 00:00

  • PCV118 Fixed-Dose Combinations and Their Value to Payers

    Nov 1, 2012, 00:00

  • PHP35 Is There a Difference in Prescription Medication Utilization Between Aged Adults with and Without Disability in the United States?

    Nov 1, 2012, 00:00

  • PRM15 Assessing the Broader Impact of Vaccinations- A Government Perspective Quantitative Analytic Framework Applied to Vaccination

    Nov 1, 2012, 00:00

  • PMS63 Assessment of the Osteoporosis Self-Efficacy Scale in Relation to Osteoprotective Behaviors among Type 2 Diabetics Patients in North Malaysia

    Nov 1, 2012, 00:00

  • PIN32 Economic Evaluation of Boceprevir for the Treatment of Patients With Genotype 1 Chronic Hepatitis C Virus Infection in Hungary

    Nov 1, 2012, 00:00

  • PMD19 Budget Impact Analysis of Balloon Sinuplasty Versus Classic Functional Endoscopic Sinus Surgery. Using a Budget Impact Model to Identify Country Specific Market Access Strategy

    Nov 1, 2012, 00:00

  • PRM78 Mapping of the National Eye Institute 25-Item Visual Functioning Questionnaire (VFQ-25) to EQ-5D Utility Scores

    Nov 1, 2012, 00:00

  • PCN159 Melody Brazil - Treatment Patterns in Brazilian Health Care System

    Nov 1, 2012, 00:00

  • PGI40 Physician-Initiated Treatment Patterns of Ulcerative Colitis (UC) Patients in the UK- a Review of Chart-Abstracted Data

    Nov 1, 2012, 00:00

  • PSY30 Cost-Effectiveness of Ustekinumab in the Management of Moderate-to-Severe Plaque Psoriasis in Mexico

    Nov 1, 2012, 00:00

  • PHP138 Impact of Value Based Pricing on Future of Patient Access Schemes in the UK

    Nov 1, 2012, 00:00

  • PMD29 Comparing the Economic Impact of Prosthesis Choice in Unicompartmental Knee Arthroplasty Procedures- Development of an Economic Model

    Nov 1, 2012, 00:00

  • PRS3 Real World Effectiveness and Relative Effectiveness of Omalizumab. An Historic-Prospective Design Study

    Nov 1, 2012, 00:00

  • PHS81 Health Care Organizations/Services Clustering- Comparison of Several Techniques Using UK Data

    Nov 1, 2012, 00:00

  • PCV67 Mind the Gap! Geographic Transferability of Economic Evaluation in Health

    Nov 1, 2012, 00:00

  • PSS8 Health Burden of Vision Problems in Asia- A Study of Malays and Indians in Singapore

    Nov 1, 2012, 00:00

  • PHP37 New Classification of Traditional and Innovative Pharmaceutical Payment Methods

    Nov 1, 2012, 00:00

  • PSY42 Effectiveness and Safety of Anti-TNF Agents in Treatment of Moderate to Severe Psoriasis Vulgaris- Results of Work Productivity and Daily Activity Impairment

    Nov 1, 2012, 00:00

  • PRM108 Reliability, Validity, and Ability to Detect Change of the Fact-an for Use in Patients With Anaemia Associated With Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PDB49 Cost and Health Care Resources Utilization in the Management of Cushing'S Disease- An Analysis Based on the Ramq Database

    Nov 1, 2012, 00:00

  • PCV112 Dosage Analysis of CHF Therapies on the Basis of Hungarian Claim Database

    Nov 1, 2012, 00:00

  • PND3 Relapses Requiring Intravenous Steroids and Multiple Sclerosis-Related Hospitalizations- Findings From the Phase 3 Define and Confirm Studies

    Nov 1, 2012, 00:00

  • PHP58 Direct Cost of Adverse Drug Reaction Treatment in Hospitalized Patients in Nakhon Pathom Hospital, Thailand

    Nov 1, 2012, 00:00

  • PMD81 Evaluation of Product Wastage From Modern Human Growth Hormone Administration Devices

    Nov 1, 2012, 00:00

  • PHP30 Using Nationwide Administrative Data to Evaluate Generic Drug Pricing and Physician Prescription

    Nov 1, 2012, 00:00

  • PRM140 An Applied Comparison of Meta-Analysis Techniques Using Bacille Calmette Guerin Vaccine Studies

    Nov 1, 2012, 00:00

  • PHS90 How Do Pharmacists Advise Diabetes Patient Self-Management During the Holy Month of Ramadan?

    Nov 1, 2012, 00:00

  • PRM94 A New Step in the Use of Computer Adaptive Tests for Measuring Quality of Life. Cultural Adaptation and Calibration in Spain of Two Promis Item Banks- Pain-Behaviour and Pain-Interference

    Nov 1, 2012, 00:00

  • PMD32 Outcomes and Costs of Isolated Aortic Valve Replacements Associated With the Mini-Invasive Implantation of a New Sutureless and Collapsed Valve in Italy, France, Germany, and UK

    Nov 1, 2012, 00:00

  • PCN138 Patterns of Anticoagulant Use in Cancer Patients Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PRM13 Methods for Estimating Survival Benefits in the Presence of Treatment Crossover- A Simulation Study

    Nov 1, 2012, 00:00

  • PMD67 The Cost Effectiveness of Platelet Rich Plasma Versus Corticosteroids in the Treatment of Lateral Epicondylitis

    Nov 1, 2012, 00:00

  • PRM4 Assessment of Immunosuppressive Therapies for Renal Transplantation - Criteria Considered for Evaluation by the EMA, European HTA Agencies and the German IQWiG

    Nov 1, 2012, 00:00

  • PCV30 Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, Pentoxifylline and Inositol Nicotinate for the Treatment of Intermittent Claudication in People with Peripheral Arterial Disease in the Uk

    Nov 1, 2012, 00:00

  • PMD12 A Budget Impact Model to Investigate Potential Cost Savings Associated With the Use of Safety-Engineered Sharp Devices in Belgium

    Nov 1, 2012, 00:00

  • PHP64 Analyzing the Annual Adverse Drug Reactions at a Regional Teaching Hospital of Southern Taiwan

    Nov 1, 2012, 00:00

  • PSY33 Item Reduction and Assessment of Measurement Properties of the Hunter Syndrome – Functional Outcomes for Clinical Understanding Scale (HS-FOCUS)

    Nov 1, 2012, 00:00

  • PMS4 Comparing the Efficacy and Safety of Biologics for the Treatment of Rheumatoid Arthritis Patients- A Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PHP192 Recent Global Insights Into Risk Sharing Agreements- A Comparative Analysis

    Nov 1, 2012, 00:00

  • PIN68 Cost-Minimization Analysis of Caspofungin Versus Liposomal Amphotericin B for the Treatment of Febrile, Neutropenic Patients With a Presumed Fungal Infection in the Netherlands

    Nov 1, 2012, 00:00

  • Instructions for Authors

    Nov 1, 2012, 00:00

  • PMH26 Cost-Effectiveness of Atypical Versus Typical Antipsychotics in Patients With Schizophrenia in Russia

    Nov 1, 2012, 00:00

  • PHP155 A Comparative Study of the Multiple Technology Assessment Process in the UK and Australia

    Nov 1, 2012, 00:00

  • PMH46 Determinants of Health-Related Quality of Life in Japanese Patients With Chronic Schizophrenia

    Nov 1, 2012, 00:00

  • PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes Mellitus

    Nov 1, 2012, 00:00

  • PRM81 Methods of Obtaining Evidence From Published Survival Data for Use in Decision Analytic Models

    Nov 1, 2012, 00:00

  • PSU26 Health-Related Quality of Life in Familial Amyloidotic Polyneuropathy Before and After Liver Transplantation- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PHP17 Consumption Patterns, Traditional Market and Regulation in the Pharmaceutical Industry. Evidence for Two Therapeutic Groups in Insured Population

    Nov 1, 2012, 00:00

  • PIH36 Quality of Life of Medical University of Warsaw Faculty of Pharmacy Students in 2010-2012

    Nov 1, 2012, 00:00

  • PCV26 Lifetime Cost-Effectiveness Analysis of Ticagrelor in Patients With Acute Coronary Syndromes Based on the Plato Trial- A Singapore Health Care Perspective

    Nov 1, 2012, 00:00

  • PRM23 Cost-Effectiveness Versus Patient Acceptability- The Exemplar of CFS/ME

    Nov 1, 2012, 00:00

  • PIN27 Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis Among Hematologic Patients in Germany

    Nov 1, 2012, 00:00

  • PSU3 Prolonged Effectiveness of Coronary Artery Bypass Surgery Versus Drug-Eluting Stents in Diabetics With Multi-Vessel Disease- An Updated Meta-Analysis

    Nov 1, 2012, 00:00

  • PND45 Differential Outcomes in Patients With Alzheimer'S Disease (AD) Treated With Donepezil 23

    Nov 1, 2012, 00:00

  • DU4 Inappropriate Use of Drugs Influences Health Budget of Population

    Nov 1, 2012, 00:00

  • PMH37 Systematic Review of Health State Utilities in Attention Deficit Hyperactivity Disorder (ADHD)

    Nov 1, 2012, 00:00

  • PDB51 Resource Utilization in the Management of Acromegaly- An Analysis From Southwest Ontario

    Nov 1, 2012, 00:00

  • PHP26 Consumption of Antidiabetics in Serbia in 2010- A Comparison with Croatia and Denmark

    Nov 1, 2012, 00:00

  • PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis

    Nov 1, 2012, 00:00

  • PHS36 Cost Drivers of Household Treatment of Presumptive Malaria in Home-Based Management of Malaria in Ejisu-Juaben Municipality

    Nov 1, 2012, 00:00

  • PHP152 The Early Benefit Assessment of Drugs That are Launched Before 2011

    Nov 1, 2012, 00:00

  • PHS28 The Cost of Management of Patients With Atrial Fibrillation - An Observational Study in UK NHS Primary Care

    Nov 1, 2012, 00:00

  • PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension

    Nov 1, 2012, 00:00

  • PRM173 On the Probability of Intertemporal Indifference

    Nov 1, 2012, 00:00

  • PIH12 Burden of Early-Onset Neonatal Sepsis in the Russian Federation

    Nov 1, 2012, 00:00

  • CN3 Cost-Effectivessness Analysis of Treatments in Adult Cancer Patients With Low Risk Febrile Neutropenia in Thailand

    Nov 1, 2012, 00:00

  • PHS5 Assessing the Clinical and Economic Burden of United States Veteran Ankylosing Spondylitis Patients

    Nov 1, 2012, 00:00

  • PDB3 Epidemiology, Patient Burden and Related Costs of Obesity in China

    Nov 1, 2012, 00:00

  • RE2 A Detailed Comparison of Dutch and Swedish Drug Reimbursement Decisions- What Evidence is Available, Which Criteria are Used, and is the Decision-Making Process Transparent?

    Nov 1, 2012, 00:00

  • PGI6 Adherence to 5-Aminosalicylic Acid (5-ASA) Therapy for Ulcerative Colitis (UC)- Impact on Health Care Costs

    Nov 1, 2012, 00:00

  • PMD65 The Cost Effectiveness of Hand Held Ultrasound Scanning for AAA in Elderly Subjects With a History of Smoking

    Nov 1, 2012, 00:00

  • PHP4 Financial Penalties for Improving Drug Adherence

    Nov 1, 2012, 00:00

  • PGI15 Cost-Effectiveness Analysis of Lactest, a New Diagnostic Drug Test for Hypolactasia in Spain

    Nov 1, 2012, 00:00

  • PHP42 Health Economics in the Czech Republic and Insurance Coverage Decision Making in 2008-2009- A Retrospective Analysis

    Nov 1, 2012, 00:00

  • PCV93 Study of the Use of Quality of Life Questionnaires in Cardiac Diseases in Poland

    Nov 1, 2012, 00:00

  • PHP180 Multiple Correspondence Analysis to Understand the Role of Multiprofessional Team for Shared Decision Making to Implementation in Clinical Practice

    Nov 1, 2012, 00:00

  • PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases

    Nov 1, 2012, 00:00

  • PMD89 Diagnostic Accuracy of Early Biomarkers for Acute Coronary Syndrome (ACS)

    Nov 1, 2012, 00:00

  • PRS7 The Effect of Chronic Obstructive Pulmonary Disease (COPD) on Health Status in Urban China

    Nov 1, 2012, 00:00

  • PSS26 Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA)- An Integrated Approach of Outcomes Measurement in Nail Psoriasis

    Nov 1, 2012, 00:00

  • PHP26 Registries of Medical Devices in the European Union

    Nov 1, 2012, 00:00

  • PHP29 Innovative Technologies - Factors Influencing Financing Decisions in Italian Hospitals

    Nov 1, 2012, 00:00

  • PCV23 Beta Blockers for Treatment of Chronic Heart Failure in Spain- Review of the Economic Evidence and Efficiency Analysis

    Nov 1, 2012, 00:00

  • CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in Fran Results From the Network RREPS

    Nov 1, 2012, 00:00

  • PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1

    Nov 1, 2012, 00:00

  • PMS11 Budget Impact Analysis in Spanish Patients With Dupuytren's Contracture- Fasciectomy Versus Collagenase Clostridium Histolyticum

    Nov 1, 2012, 00:00

  • PCV94 The Influence of Disease-Specific Symptoms on the Health-Related Quality of Life in Patients With Atrial Fibrillation

    Nov 1, 2012, 00:00

  • PRM143 Cluster Analysis and Principal Component Analysis to Assess the Variability of Data in Cost Evaluations- Methods and Applications in Oncology

    Nov 1, 2012, 00:00

  • PIH16 Epidemiology of Herpes Zoster and Its Related Resource Utilization- A Large Population-Based Study in Israel

    Nov 1, 2012, 00:00

  • PRS13 Discriminating the Price of a Product Based on the Target Patient Segment by Launching Different Delivery Mechanisms- A Comparison of China, India and Korea

    Nov 1, 2012, 00:00

  • PMS19 Investigation of Comparative Clinical Outcomes Profiles and Cost Effectiveness of Four Classes of Anti Arthritic Drugs Using HAQ DI, DAS -28 and EQ5D3L in a Tertiary Care Hospital in Western India

    Nov 1, 2012, 00:00

  • PCV25 A Pharmacoeconomic Assessment of Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in a Tertiary Hospital in China

    Nov 1, 2012, 00:00

  • PCN20 Inhaled Corticosteroid Use and Risks of Lung Cancer and Laryngeal Cancer

    Nov 1, 2012, 00:00

  • PUK1 A Swedish Prospective Observational Study to Evaluate the Impact in Quality of Life Among Previously Untreated Patients Receiving Their First Prescription of Solifenacin. (SPOQ-Study)

    Nov 1, 2012, 00:00

  • PHP162 Review of NICE's Technology Appraisal Recommendations

    Nov 1, 2012, 00:00

  • ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PMS65 Detecting Potential Fibromyalgia Patients in Primary Care Settings- Validation of the Fibrodetect Screening Tool

    Nov 1, 2012, 00:00

  • PGI34 A Patient-Reported Outcome Model for Crohn's Disease

    Nov 1, 2012, 00:00

  • PCN3 Quality-Adjusted Survival in Patients With Wild-Type (WT) KRASs Metastatic Colorectal Cancer (mCRC) Receiving First-Line Therapy With Panitumumab Plus FOLFOX Versus FOLFOX Alone

    Nov 1, 2012, 00:00

  • PMS33 Cost-Efficacy Analysis of Biologic Drugs in Combination With DMARDs in Patients With Active Rheumatoid Arthritis and Inadequate Response to Traditional DMARDs in Portugal – A Simplified Approach

    Nov 1, 2012, 00:00

  • PSY29 Title- The Challenge of Conducting a Prospective Economic Evaluation of a Pharmacogenetic Test

    Nov 1, 2012, 00:00

  • PSY2 Preliminary Validation of Collect Scale- A Co-Morbidity Assessment Tool for Patients With Chronic Lymphocytic Leukaemia

    Nov 1, 2012, 00:00

  • PDB32 Diabetic Foot Syndrome Hospitalization Costs in Poland

    Nov 1, 2012, 00:00

  • PRM41 Designing Patient Registries- A Case-Study Using an Online Interactive Data Analysis Tool

    Nov 1, 2012, 00:00

  • PDB29 Cost-Effectiveness Modelling of Type-1 Diabetes

    Nov 1, 2012, 00:00

  • PMD24 Economical Aspects of the Reimbursement of Extracorporeal Photopheresis (ECP) in Treatment of Patients With Graft-Versus-Host Disease (GvHD) After Allogeneic Hematopoietic Cell Transplantation (HCT) Who are Refractory to Steroid Treat ...

    Nov 1, 2012, 00:00

  • PMD71 The Switch Study- The Impact of Continuous Glucose Monitoring on Health Care Resource Utilization

    Nov 1, 2012, 00:00

  • PMD56 Cost-Efectiveness Analysis Comparing the Application or Not of Whole Brain Irradiation Before Stereotectic Radiosurgery for the Treatment of One to Four Brain Metastases, According to Brazilians Third-Party Private Payer's Perspective ...

    Nov 1, 2012, 00:00

  • PND63 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis- Findings From the Phase 3 Define Study

    Nov 1, 2012, 00:00

  • PRM7 Increasing Physical Activity in Patients With Chronic Disease- What is the Literature Telling Us?

    Nov 1, 2012, 00:00

  • PHP39 Explaning Differences in EU5 Market Penetration Levels and Rates of Biosimilars- The Case of Epoetine, Granulocyte-Colony Stimulating Factor, and Growth Hormones

    Nov 1, 2012, 00:00

  • PRM165 Validating Health Economic Models- Developing a Methodological Approach

    Nov 1, 2012, 00:00

  • PDB5 Real-World Treatment Patterns and Outcomes When Initiating Once-Daily Injectable Pen Therapy with Insulin Glargine or Liraglutide – an Electronic Medical Records Study

    Nov 1, 2012, 00:00

  • PRM100 Converting EORTC QOl-C30 Scores to Utility Values- Is it Plausible?

    Nov 1, 2012, 00:00

  • PND73 Multiple Sclerosis in Germany- Outpatient Health Care Patterns

    Nov 1, 2012, 00:00

  • PRM175 Identification and Translation of Culturally Bound Terms in Patient Reported Outcome Measures

    Nov 1, 2012, 00:00

  • PR4 The Effect of Neuropathic Pain on Health Status, Work Productivity Loss, and Health Care Resource Use in Japan

    Nov 1, 2012, 00:00

  • PHP95 Factors Associated with Physician Participation in a National Continuing Medical Education Program

    Nov 1, 2012, 00:00

  • PIH2 Topical Estrogen Therapy in Postmenopausal Women - Indian Experience

    Nov 1, 2012, 00:00

  • PSY18 Clinical Outcomes, Resource Utilization and Treatment Cost of Myelodysplastic Syndromes and Acute Myeloide Leukemia in a Real World Setting- Single-Center Experience

    Nov 1, 2012, 00:00

  • PHS34 The Cost of Management of Common Cardiovascular Diseases is Higher on Weekends As Compared to Weekdays

    Nov 1, 2012, 00:00

  • ME3 Censor Adjusted Net Monetary Benefit of Anti-HCV Therapy in the Variety of Real-World Treatment Setting

    Nov 1, 2012, 00:00

  • PSS20 Cost-Utility Analysis of Treatments for Macular Edema Secondary to Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PMS5 Benefit-Risk Analysis of Adalimumab and Alternative Treatments for Moderate-to-Severe Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PIH45 Comparison of Unintended Pregnancy Rates in Users of 84/7, 21/7, and 24/4 Oral Contraceptive Regimens

    Nov 1, 2012, 00:00

  • PSS6 Cost-of-Illness of Chronic Lymphoedema Patients in Hamburg and Suburban Region

    Nov 1, 2012, 00:00

  • PHS98 Clinical Characteristics, Treatment Patterns, and Resource Utilization in a Real-World European Population With Diverticulitis

    Nov 1, 2012, 00:00

  • PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis Media

    Nov 1, 2012, 00:00

  • PRM86 Utilizing Indirect Treatment Comparisons in Metastatic Castration Resistant Prostate Cancer (mCRPC)

    Nov 1, 2012, 00:00

  • PIN2 Assessing the Diagnostic Performance of Human Immunodeficiency Virus Type 1 (HIV-1) Tropism Testing Methods- A Systematic Review of Genotypic Sequencing of the Third Hypervariable (V3) Loop and Enhanced-Sensitivity Phenotypic Assay Tec ...

    Nov 1, 2012, 00:00

  • PIN45 Health Economic Impact of Infant Vaccination Program With PHiD-CV and PCV13 Using New Efficacy/Effectiveness Data. Example of Finland

    Nov 1, 2012, 00:00

  • PHP183 The Rocky Road to Market Equilibrium – Price Regulation and Entry Liberalization in Portuguese Retail Pharmacy

    Nov 1, 2012, 00:00

  • PDB19 Estimating the Costs of Diabetes Mellitus- An Analysis in Malaysia

    Nov 1, 2012, 00:00

  • PHP153 Supporting Payers with Collaborative HTA Tools in Making Evidence-Based Decisions- The United States Experience and International Needs in Europe and Globally

    Nov 1, 2012, 00:00

  • PCN112 Characteristics of Cancer Patients Who Seek Cytostatic Therapy in Korea- A Pilot Study

    Nov 1, 2012, 00:00

  • PHS84 Analyzing Pharmaceutical Expenditure in GreeUnwinding Ariadne's Clue

    Nov 1, 2012, 00:00

  • PCN18 Economic Evaluation of CT Colonography (CTC) Introduction Into the Colorectal Cancer Screening Program in Japan

    Nov 1, 2012, 00:00

  • PGI14 Knowledge, Attitude and Practices Towards Hepatitis-B Among General Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany

    Nov 1, 2012, 00:00

  • PHS50 Health Care Resource Use and Cost in Alzheimer's Disease in Three European Countries – Baseline Findings of the GERAS Study

    Nov 1, 2012, 00:00

  • PCN45 Economic Evaluation of Using Branded Taxotere® Versus Generic Docetaxel- Based on Decision Tree Model

    Nov 1, 2012, 00:00

  • PMD55 Sacral Nerve Modulation (SNM) for the Treatment of Idiopathic Refractory Overactive Bladder- Cost-Effective in the UK Compared to Optimal Medical Therapy, Botulinum Toxin a (BoNT-A) and Percutaneous Tibial Nerve Stimulation (PTNS)

    Nov 1, 2012, 00:00

  • PUK3 Evaluation on Health Expenditure Among Patients With Neurogenic Detrusor Overactivity After Spinal Cord Injury

    Nov 1, 2012, 00:00

  • PIN67 Cost Minimization Comparison of a Vaccination With Campaign Program for Corporations Using PCV13 Vesus Free PCV10 With Paid Campaign

    Nov 1, 2012, 00:00

  • PHP113 The Importance of Economic Evaluations in the Assessment of Reimbursement Applicaitions

    Nov 1, 2012, 00:00

  • PDB34 Improvements in Quality of Life Associated With Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients in China- Results from the A1Chieve Observational Study

    Nov 1, 2012, 00:00

  • PIN13 The Clinical Burden of Hospitalized All-Cause Pneumonia in the Lombardia and Puglia Regions of Italy, 2007–2009

    Nov 1, 2012, 00:00

  • PIH28 The Project Sincope in Triveneto (PROSIT) Study. A Multicenter Study Regarding Syncope Management in an Italian Region

    Nov 1, 2012, 00:00

  • PDB46 Anti-Diabetic Drugs and In-Patient Admissions Attributable to Diabetes in Portugal

    Nov 1, 2012, 00:00

  • PCV2 Comparative Efficacy and Safety Analysis of Atrial Fibrillaion Patients Treated with Dabigatran in RE-LY Study (CHADS 2 Score of 3 or Greater ) Versus Rivaroxaban in ROCKET-AF

    Nov 1, 2012, 00:00

  • PMS19 Indirect Costs Associated With Ankylosing Spondylitis in Turkey

    Nov 1, 2012, 00:00

  • PCN134 Expenditures and Availability of Orphan Drugs in the Czech Republic- Seven Year Experience (2004 – 2010)

    Nov 1, 2012, 00:00

  • PIN21 Economic Impact of Hospital-Acquired Infections in Mechanically Ventilated Patients in Intensive Care Units- Retrospective Analysis From a United States Hospital Database

    Nov 1, 2012, 00:00

  • PHP70 A Systematic Review of Hospital-at-Home Care- Cost Savings are Overestimated

    Nov 1, 2012, 00:00

  • PSU36 Evidence Based Medicine- A Case Study of its Application to Innovative Surgical Procedures in the UK

    Nov 1, 2012, 00:00

  • PCN31 Treatments Pattern and Outcomes of Ovarian Cancer Patients in a Patient-Centered Retrospective Research Registry

    Nov 1, 2012, 00:00

  • PSU15 Clinical and Economic Burden of Anastomotic Leaks After Colorectal Surgeries

    Nov 1, 2012, 00:00

  • PHS95 The Suicidality in Thai Population- A National Survey

    Nov 1, 2012, 00:00

  • PMH9 Cost Consequences of Non-Compliance in Schizophrenia Treatment – A Literature Review

    Nov 1, 2012, 00:00

  • PSS16 Cost-Effectiveness of Tacrolimus Ointment in Children With Moderate and Severe Atopic Dermatitis- Twice-Daily Maintenance Treatment Versus Standard Twice-Daily Reactive Treatment of Exacerbations From the Perspective of the Spanish Na ...

    Nov 1, 2012, 00:00

  • PSS10 Economical Burden of Severe Visual Impairment and Blindness – a Systematic Review

    Nov 1, 2012, 00:00

  • PMH44 Validity and Responsiveness of the EQ-5D and the Kidscreen-10 in Children With ADHD

    Nov 1, 2012, 00:00

  • PIH10 Cost Effectiveness Comparison Between Dienogest and Gonadotropin-Releasing Hormone Analogs in Turkey

    Nov 1, 2012, 00:00

  • PCN116 Mapping FACT-P to EQ-5D in a Large Cross-Sectional Study of Metastatic Castrate-Resistant Prostate Cancer Patients

    Nov 1, 2012, 00:00

  • PHP43 How Will Health Care Reform in Russia Affect Drug Pricing and Reimbursement?

    Nov 1, 2012, 00:00

  • PIN15 Economic Evaluation of Vaccination in Southeast Asian Countries- A Systematic Review

    Nov 1, 2012, 00:00

  • PMH3 Intravenous Droperidol and Olanzapine as Adjuncts to Midazolam for the Acutely Agitated Patient- A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Clinical Trial

    Nov 1, 2012, 00:00

  • PRM148 Sample Size and Power Considerations in Network Meta-Analysis

    Nov 1, 2012, 00:00

  • PMD74 The Relationship Between Treatment Satisfaction and Health Status among Those With Type 1 Diabetes

    Nov 1, 2012, 00:00

  • PHS83 Potential Time Savings With Rituximab Subcutaneous (SC) Injection Versus Rituximab Intravenous (IV) Infusion- Results from Interviews at 13 European Sites As Part of a Time and Motion Study (TM)

    Nov 1, 2012, 00:00

  • PIN3 Evaluation of the Relationship Between Vancomycin Trough Concentration and Clinical Outcome in Hospitalized Patients With Orsa Bacteremia and the Relationship Between Vancomycin Trough Concentration and Nephrotoxicity

    Nov 1, 2012, 00:00

  • PMD1 Economic Value of Screening for Early Parkinson's Disease in a European Setting

    Nov 1, 2012, 00:00

  • PHS44 Economic Evaluation of Universal Hepatitis B Vaccination Strategy in Japan

    Nov 1, 2012, 00:00

  • PIN70 Cost-Effectiveness of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients With Peginterferon Alfa-2A in Italy

    Nov 1, 2012, 00:00

  • PMH15 An Economic Systematic Review on Bipolar Disorder in Children and Adolescents- Cost-Effectiveness of Treatments, Costs of Care and Quality of Life

    Nov 1, 2012, 00:00

  • PHP45 Impact of Generics Policy on the Generic Penetration

    Nov 1, 2012, 00:00

  • PIN13 Cost of Antibiotics Used for Nosocromaial Infection Treatment in Inpatient Department at Nakhon Pathom Hospital

    Nov 1, 2012, 00:00

  • PCV51 Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Adult Patients With Non-Valvular Atrial Fibrillation with One or More Risk Factors – A UK Perspective

    Nov 1, 2012, 00:00

  • PMS10 Hospitalization Costs and Their Predictors in Patients with Rheumatoid Arthritis in Urban China

    Nov 1, 2012, 00:00

  • PCV61 Pharmacoeconomic Evaluation of Olmesartan, Losartan and Valsartan in Treatment of Essential Arterial Hypertension

    Nov 1, 2012, 00:00

  • PRM53 Can the Disutility of Allergic Rhinitis and Conjunctivitis Be Calculated From the Aggregated Total Symptoms Score?

    Nov 1, 2012, 00:00

  • PHP91 Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the Evidence

    Nov 1, 2012, 00:00

  • PMH50 Differences in Treatment Patterns and Characteristics in Patients With Bipolar Disorder - A Retrospective Real Life Study in Sweden

    Nov 1, 2012, 00:00

  • PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in Spain

    Nov 1, 2012, 00:00

  • PMS11 The Inpatient Costs and Their Predictors in Patients with Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00

  • PHS61 Patient Involvement in Treatment Decisions and Its Perceived Impact on Patient Outcomes in Systemic Lupus Erythematosus (SLE)- A Comparison of Physician and Patient Perspectives

    Nov 1, 2012, 00:00

  • PHS77 Cancer Network Pharmacists Perspective of the First Year of the Cancer Drugs Fund

    Nov 1, 2012, 00:00

  • PCV28 2-Year Incidence of Stroke and Hemorrhages Hospitalizations and Costs Within Atrial Fibrillation Patients in France

    Nov 1, 2012, 00:00

  • PRS44 The Impact Made by the Continuity of Care for COPD Patients on Health Outcomes and Medical Cost in Korea, According to the National Health Insurance Database

    Nov 1, 2012, 00:00

  • PMS2 Improvements in Physical Function and Disability in Patients With Rheumatoid Arthritis After Treatment With NNC0109-0012 (Anti-IL-20 mAb) in a Phase 2A Trial

    Nov 1, 2012, 00:00

  • PCN92 Cost-Effectiveness of Nilotinib Versus Imatinib as First-Line Treatment for Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in the Chronic Phase (CML-CP) in Russian Federation

    Nov 1, 2012, 00:00

  • PSY32 Measuring the Level Impact of Neuropathic Pain in the EU

    Nov 1, 2012, 00:00

  • PSS12 Nepafenac for the Reduction in Risk of Post-Operative Macular Oedema Associated With Cataract Surgery in Diabetic Patients- A Cost-Effectiveness Estimation for Scotland

    Nov 1, 2012, 00:00

  • PSU31 The Association Between Degenerative Disk Disease and Outcomes Among Patients Undergoing Lumbar Fusion Surgery

    Nov 1, 2012, 00:00

  • PIN54 Evaluation of Skin Tests in the Diagnostics of Tuberculosis Infection

    Nov 1, 2012, 00:00

  • PRM32 Reliability and Validity of an Instrument Used in a Tobacco Cessation Intervention Study Among Patients With Diabetes

    Nov 1, 2012, 00:00

  • PHP85 The Benefits of Using OTC- A Systematic Literature Review

    Nov 1, 2012, 00:00

  • PSY17 Cost-Utility Analysis of Immune Tolerance Induction (ITI) Therapy Versus On-Demand Treatment With Recombinant FVII (rFVIIa) for Hemophilia A With High Titer Inhibitors in Iran

    Nov 1, 2012, 00:00

  • PGI13 Vaccination Status Against Hepatitis B Among Healthy Population of Quetta, Pakistan

    Nov 1, 2012, 00:00

  • PSY12 The Prevalence and Treatment Status of Hemophilia in India, Russia, Taiwan and Turkey- A Systematic Review and Meta Analysis

    Nov 1, 2012, 00:00

  • PMS46 Economic Evaluation of Adalimumab for the Treatment of Early-and Late-Stage Rheumatoid Arthritis in Italy

    Nov 1, 2012, 00:00

  • PCN27 Disclosing Complementary and Alternative Medicines (CAM) Use to the Health Care Providers-A Descriptive Study

    Nov 1, 2012, 00:00

  • PSY20 Infliximab Significantly Improves Symtoms and Quality of Life in Patients With Ankylosing Spondylitis in China

    Nov 1, 2012, 00:00
  • «
  • 121 (current)
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »